BUHLMANN News - Buhlmann Diagnostics Corp - Newsletter - Tradeshow

BUHLMANN News

Come Visit BUHLMANN at AMLI 2017- Booth #13

   AMLI 2017 BUHLMANN Diagnostics Corp  Booth: #13 August 13 - 16, 2017 Renaissance Stapleton Hotel | Denver, C0 Connect with our ...

Turbo Charged from the Start: Introducing in-house Calprotectin Testing Directly on the Roche cobas® c702

Rosie Forster, Queen Elizabeth Hospital Birmingham, with the CALEX and Roche cobas c702 BÜHLMANN fCAL® turbo is for Research ...

Evaluation of the BÜHLMANN fCAL® turbo Test at Laborgemeinschaft 1 in Zurich

BÜHLMANN fCAL® turbo is for Research Use Only in the US. Not to be used in diagnostic procedures. Health Canada ...

Visit BUHLMANN Diagnostics Corp at AACC 2017

  AACC 2017 BUHLMANN Diagnostics Corp  Booth: #1620 July 30 – August 3 2017, 2017 San Diego Convention Center | San Diego, ...

Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray BS-200E and Cobas® c111

BÜHLMANN fCAL® turbo: Mandic-Havelka, A. Nilsen, T. et. al. Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray ...

BUHLMANN LabSense News: Spring 2017 Edition

BUHLMANN Diagnostics Corp is proud to release the third edition of our newsletter. View the latest information, new happenings, products ...

Visit BUHLMANN at DDW 2017- Booth 1925

Digestive Diseases Week (DDW) 2017 BUHLMANN Diagnostics Corp  Booth: #1925 May 06 - 09, 2017 | McCormick Place | Chicago, IL ...

New Health Canada Licences: Quantum Blue® Infliximab Assay, IBDoc®,CALEX® Cap

BUHLMANN Diagnostics Corp (BDC), BÜHLMANN Laboratories AG’s North American affiliate is proud to announce that three of its novel products, ...